Literature DB >> 22623539

Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.

Sadhna Verma1, Baris Turkbey, Naira Muradyan, Arumugam Rajesh, Francois Cornud, Masoom A Haider, Peter L Choyke, Mukesh Harisinghani.   

Abstract

OBJECTIVE: This article is a primer on the technical aspects of performing a high-quality dynamic contrast-enhanced MRI (DCE-MRI) examination of the prostate gland.
CONCLUSION: DCE-MRI is emerging as a useful clinical technique as part of a multi-parametric approach for evaluating the extent of primary and recurrent prostate cancer. Performing a high-quality DCE-MRI examination requires a good understanding of the technical aspects and limitations of image acquisition and postprocessing techniques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623539      PMCID: PMC6309691          DOI: 10.2214/AJR.12.8510

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  67 in total

Review 1.  Dynamic contrast-enhanced magnetic resonance imaging in oncology.

Authors:  M V Knopp; F L Giesel; H Marcos; H von Tengg-Kobligk; P Choyke
Journal:  Top Magn Reson Imaging       Date:  2001-08

2.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI.

Authors:  A R Padhani; V S Khoo; J Suckling; J E Husband; M O Leach; D P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-06-01       Impact factor: 7.038

Review 3.  Angiogenesis in prostate cancer: biology and therapeutic opportunities.

Authors:  B Nicholson; G Schaefer; D Theodorescu
Journal:  Cancer Metastasis Rev       Date:  2001       Impact factor: 9.264

4.  The theory and applications of the exchange of inert gas at the lungs and tissues.

Authors:  S S KETY
Journal:  Pharmacol Rev       Date:  1951-03       Impact factor: 25.468

5.  Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results.

Authors:  K Ogura; S Maekawa; K Okubo; Y Aoki; T Okada; K Oda; Y Watanabe; C Tsukayama; Y Arai
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

6.  Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Authors:  M W Kattan; T M Wheeler; P T Scardino
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

7.  Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

Authors:  Deborah A Kuban; Howard D Thames; Larry B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

8.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.

Authors:  Marc R Engelbrecht; Henkjan J Huisman; Robert J F Laheij; Gerrit J Jager; Geert J L H van Leenders; Christina A Hulsbergen-Van De Kaa; Jean J M C H de la Rosette; Johan G Blickman; Jelle O Barentsz
Journal:  Radiology       Date:  2003-08-27       Impact factor: 11.105

9.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Authors:  Misop Han; Alan W Partin; Marianna Zahurak; Steven Piantadosi; Johnathan I Epstein; Patrick C Walsh
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  77 in total

Review 1.  Anatomic and Molecular Imaging in Prostate Cancer.

Authors:  Eric T Miller; Amirali Salmasi; Robert E Reiter
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 2.  Current trends and new frontiers in focal therapy for localized prostate cancer.

Authors:  Melissa H Mendez; Daniel Y Joh; Rajan Gupta; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

3.  A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.

Authors:  Andriy Fedorov; Jacob Fluckiger; Gregory D Ayers; Xia Li; Sandeep N Gupta; Clare Tempany; Robert Mulkern; Thomas E Yankeelov; Fiona M Fennessy
Journal:  Magn Reson Imaging       Date:  2014-01-21       Impact factor: 2.546

4.  Role of MRI for the detection of prostate cancer.

Authors:  Richard C Wu; Amir H Lebastchi; Boris A Hadaschik; Mark Emberton; Caroline Moore; Pilar Laguna; Jurgen J Fütterer; Arvin K George
Journal:  World J Urol       Date:  2021-01-04       Impact factor: 4.226

5.  Diagnostic value of semi-quantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.

Authors:  Elke Hauth; Daniela Halbritter; Horst Jaeger; Horst Hohmuth; Meinrad Beer
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

6.  Quantitative effects of acquisition duration and temporal resolution on the measurement accuracy of prostate dynamic contrast-enhanced MRI data: a phantom study.

Authors:  Silvin Paul Knight; Jacinta Elizabeth Browne; James Frances Mary Meaney; Andrew John Fagan
Journal:  MAGMA       Date:  2017-04-10       Impact factor: 2.310

7.  Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma.

Authors:  Xuemei Du; Ying Gao; Hongyu Zhao; Bin Li; Weimin Xue; Daye Wang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

8.  Effect of parallel radiofrequency transmission on arterial input function selection in dynamic contrast-enhanced 3 Tesla pelvic MRI.

Authors:  Hatim Chafi; Saba N Elias; Huyen T Nguyen; Harry T Friel; Michael V Knopp; BeiBei Guo; Steven B Heymsfield; Guang Jia
Journal:  J Magn Reson Imaging       Date:  2015-06-09       Impact factor: 4.813

9.  The evaluation of prostate lesions with IVIM DWI and MR perfusion parameters at 3T MRI.

Authors:  Murat Beyhan; Recep Sade; Erdem Koc; Senol Adanur; Mecit Kantarci
Journal:  Radiol Med       Date:  2018-10-01       Impact factor: 3.469

Review 10.  Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.

Authors:  Alberto Diaz de Leon; Daniel Costa; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.